Creative Diagnostics offers 1400+ recombinant rabbit monoclonal antibodies validated and characterized by multiple applications with better specificity and high affinity.
Validating an antibody's specificity is crucial to ensuring the absence of nonspecific binding. One approach to address this is through knockout or knockdown of the target protein by CRISPR- or RNAi-mediated technologies.
Creative Diagnostics currently provide tetrodotoxin antigen, antibodies and ELISA kit for the determination of TTX levels, which could be used in various applications.
Creative Diagnostics offers several new ELISA Kits for quantitative and qualitative analysis of antimicrobial drugs in different kinds of samples.
Creative Diagnostics now offers high quality Tetanus (Clostridium tetani) antigens, antibodies and ELISA kits for research use.
Creative Diagnostics offers a large range of Chikungunya antigens and antibodies. These antibodies and antigens have been validated to work in various types of immunoassays and can be supplied as high quality research tools to develop sensitive and specific infectious disease assays.
Creative Diagnostic offers a complete panel of native and recombinant HSV antigens designed to meet the needs of new generation HSV multiplexed immunoassays.
Creative Diagnostics is constantly working in order to bring best-in–market reagents for troponin measurements. Now we are offering new reagents for Troponin-I antibody pair for the development of highly sensitive and specific cTnI sandwich immunoassays.
Creative Diagnostics has just released a series of Alpha viruses antigens including the capsid proteins, the nonstructural proteins and the envelope glycoproteins for relative research and hope to develop more efficient reagents to fight against this pandemic virus.
Creative Diagnostics now offers antibodies against full length or partial proteins, from the ubiquitin proteasome (UPS) pathway; these include E2 conjugating enzymes, E3 ligases, DUBs, ubiquitin binding proteins substrates and conjugate antibodies and also a number of kinase antibodies.
Creative Diagnostics has launched the most complete HPV L1 antibody products, covering HPV 6/11/16/18/31/33/45/52/58, including polyclonal, monoclonal antibody and monoclonal antibody screening set, mainly used for ELISA, Western Blot, neutralization and in vitro vaccine in vitro efficacy testing.
Creative Diagnostics offers a large range of M. Tuberculosis antigens which have been validated to work in various types of immunoassays. Several of these products are currently being used in commercial diagnostic assays.
Creative-Diagnostics has launched a powerful set of antiserum and their AP conjugate form against plant pathogens for DAS-ELISA.
Vitamin D refers to a group of fat-soluble secosteroids responsible for increasing intestinal absorption of calcium, iron, magnesium, phosphate, and zinc.
These high-affinity antibodies can be widely used as raw materials in ELISA experiment or lateral-flow immunochromatographic assay for determination of vitamin B7, B9, B12 levels in various samples.
Creative Diagnostics offers the Kanamycin ELISA Kits for quantitative analysis of kanamycin residue in animal tissues (muscle and liver, etc.) and milk etc. Each of our kits goes through fit-for-purpose validation and stability testing to ensure high accuracy, sensitivity and specificity.
Creative Diagnostics offers the Pharmacokinetics ELISA Kits for the quantitation of serum protein drug levels to provide accurate pharmacokinetic (PK) data that will guide the optimization of drug dosing regimens.
Ideally a diagnostic assay for dengue should be rapid, simple, highly sensitive and specific, and preferably able to differentiate between primary and secondary infections, as well as identify the virus serotype. Creative Diagnostics offers a range of reagents designed to develop serologic assays for the early and specific diagnosis of a dengue infection.
Two highly selective anti-human Lp-PLA2 monoclonal antibodies were recently developed by Creative Diagnostics, which make possible the development of highly sensitive and rapid sandwich immunoassays.
Creative Diagnostics has just released a series of recombinant Zika virus, Alphavirus and Marburgvirus antigens for use with biopharmaceutical, clinical, and life science research applications, as well as for in-vitro diagnostic (IVD) test kit manufacturing procedures.